Cite
HARVARD Citation
Bousiges, O. et al. (2018). Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage. Journal of neurology, neurosurgery and psychiatry. 89 (5), pp. 467-475. [Online].